Psychedelics as Anti-Inflammatory Agents
A look into the less discussed therapeutic aspect of psychedelics: the anti-inflammatory effect.
Articles
Is Cannabis a Psychedelic Drug?
Yes, and it may work via 5-HT2A as well as the cannabinoid receptors.
Women and Psychedelics: The Big Picture
As psychedelic research moves ahead, some have started to identify several topics of significant interest to women.
Chicago Follows Oakland, Introduces Resolution to Decriminalize Psychedelic Plants
Chicago could become the largest US city to decriminalize entheogens
Scientists Solve the Crystal Structure of the Fumarate Salts of DMT and Psilocin
This new knowledge provides more options for developing psychedelics into therapeutic drug formulations.
Jamaica is Home to the First Magic Mushroom Research Center
The center aims to quantify the chemicals in magic mushrooms and possibly identify new psychedelic molecules in them.
Regulatory Hurdles Facing Psychedelics
Market introduction of psychedelics as a therapy looks promising. However, policy and regulatory issues concerning the drug class still exist.
Scientists Engineer E. Coli to Produce Psilocybin
This is the first time psilocybin has been produced from a prokaryotic organism.
Usona Institute Beginning Phase 2 Clinical Trials Using Psilocybin to Treat Major Depressive Disorder
Enrollment of study volunteers is expected to start within the next two months.
The State of the Art of Psilacetin (4-AcO-DMT)
Psilacetin is easier and less expensive to make than psilocybin, but much of its pharmacology is unknown.